H K Gleeson
Overview
Explore the profile of H K Gleeson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baldeweg S, Ball S, Brooke A, Gleeson H, Levy M, Prentice M, et al.
Endocr Connect
. 2018 Jun;
7(7):G8-G11.
PMID: 29930026
Cranial diabetes insipidus (CDI) is a treatable chronic condition that can potentially develop into a life-threatening medical emergency. CDI is due to the relative or absolute lack of the posterior...
2.
Padfield P, Seckl J, Walker B, Gleeson H
J Clin Endocrinol Metab
. 2005 Aug;
90(8):4981-2.
PMID: 16087965
No abstract available.
3.
Gleeson H, Shalet S
Endocr Relat Cancer
. 2004 Dec;
11(4):589-602.
PMID: 15613441
Survival rates are improving following cancer therapy for childhood brain tumours. There is therefore a growing cohort of survivors at risk of late effects of cancer therapy. Endocrine problems are...
4.
Murray R, Darzy K, Gleeson H, Shalet S
J Clin Endocrinol Metab
. 2002 Jan;
87(1):129-35.
PMID: 11788635
Childhood survivors of cancer are prone to a number of adverse sequelae related to the therapeutic interventions undertaken to achieve remission. The endocrine system is frequently affected; hypothalamo-pituitary dysfunction, in...
5.
Gleeson H, Shalet S
Curr Opin Pediatr
. 2001 Nov;
13(4):346-51.
PMID: 11717561
Because of the increasing population of childhood cancer survivors, there is a need to focus on the late effects of cancer therapy. After discharge by their pediatric oncologists, it is...